CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 32.28
+1.58 (5.15%)
At close: Mar 27, 2026
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 13.1 billion as of March 27, 2026. Its market cap has increased by 1.17% in one year.
Market Cap
13.10B
Enterprise Value
11.58B
Revenue
1.19B
Ranking
n/a
PE Ratio
263.71
Stock Price
32.28
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 13.10B, an increase of 72.99%. That is a compound annual growth rate of 8.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 13.10B | 3.69% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OneRobotics (Shenzhen) | 23.00B |
| The United Laboratories International Holdings | 20.03B |
| Xuanzhu Biopharmaceutical | 18.18B |
| Consun Pharmaceutical Group | 14.63B |
| Sihuan Pharmaceutical Holdings Group | 12.35B |
| Ab&B Bio-Tech CO., LTD. JS | 12.14B |
| Shandong Xinhua Pharmaceutical Company | 9.80B |
| Luye Pharma Group | 9.63B |